Home Teleflex Incorporated

Teleflex Incorporated

Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019

1/16/19: “Data clearly show that both men and women have significant misconceptions about men’s health, including BPH and the ways to treat the condition,” said Ana Fadich, vice president of Men’s Health Network.

NeoTract’s UroLift® System 12-Month MedLift Study Published in Prostate Cancer and Prostatic Diseases

The MedLift Study provided clinical evidence to support the safety and efficacy of the UroLift System treatment for BPH, or an enlarged prostate, involving a median lobe obstruction.

Arrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has...

Teleflex to Showcase Key Anesthesia Products at Euroanaesthesia 2017 in Geneva

The company will showcase the LMA® Protector™ and other key products in its Anesthesia portfolio, together with...

Teleflex (TFX) Announces Commencement of Phase I Clinical Study (FDP-1) of RePlas™ Freeze-Dried Plasma

The U.S. Army is sponsoring clinical trials of novel freeze-dried plasma developed by Teleflex’s Vascular Solutions division...

Clearance for the Arrow® AC3 OptimusTM Intra-Aortic Balloon Pump (IABP)

Advanced IABP performance with the ability to provide optimized therapy to the most challenging patient conditions, even...